Content | Navigation |

Sponsored Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer Seminar Speakers

Upcoming Presentations

**All presentations at 2:30 p.m. at locations listed**

Tuesday, October 3
NDSU MU Badlands Room
“pH Responsive Polymeric Nanoparticles as Efficient Drug Delivery Agents for Pancreatic Cancer”
Priyanka Ray, Dr. Quadir's Group

Tuesday, October 17
NDSU MU Prairie Room
“Targeting RAGE in Pancreatic Cancer”  
Priyanka Swami, Dr. Leclerc’s Group 

Tuesday, October 31
NDSU MU Prairie Room
“In-vitro Study of AGE-RAGE Interaction on Pancreatic Cancer Using Prairie KPC Cell Lines”
Sakshi Taneja, Dr. Leclerc’s Group 

Tuesday, November 14
NDSU MU Prairie Room
“GSTP1 Knockdown Impairs the Growth and Proliferation of Pancreatic Ductal Adenocarcinoma (PDAC) Cells”
Rahul Singh, Dr. Reindl’s Group

Tuesday, November 28
NDSU MU Badlands Room
“Carbon Nanotube-based Lateral Flow Biosensor Strips for the Quantitative Detection of Pancreatic Cancer Biomarkers in Human Plasma”
Kwaku Baryeh, Dr. Liu’s Group

Tuesday, December 12
NDSU MU Badlands Room
“CRISPR/Cas9 Loss-of-function Library Screen to Identify Genes that Regulate Sensitivity of Pancreatic Cancer Cells to Piperlongumine”
Jiyan Mohammad, Dr. Reindl’s Group 

 

Past Presentations

Dr. Sadagopan Krishnan, Department of Chemistry, Oklahoma State University

  • “Ultrasensitive Clinical Biosensors and Microarrays for Disease Markers” – August 29, 2016

Dr. Howard Crawford, Professor, Molecular & Cellular Physiology and Internal Medicine; Director, Pancreas Research Program; Director, Animals Models of Pancreas Disease Core, University of Michigan

  • “Pancreatic Tumorigenesis:  When the Going Gets Tough, the Tufts Get Going” – October 11, 2016

Dr. Silvia Stan, Assistant Professor, Department of Nutrition Science, Purdue University

  • “Insights into the Pleiotropic Nature of Dietary Bioactives” – October 21, 2016

Dr. Channing Der, Kenan Distinguished Professor of Pharmacology, Lineberger Comprehensive Cancer Center, the University of North Carolina at Chapel Hill

  • “Drugging Undruggable KRAS for Pancreatic Cancer” – October 28, 2016

Dr. Rajesh Sardar, Associate Professor, Department of Chemistry and Chemical Biology, Indiana University – Purdue University Indianapolis

  • “PCR-Free Pancreatic Cancer Biomarker Assay in Blood:  From Bench-top to Bedside” – November 3, 2016

Dr. Raghu Kalluri, Professor, and Chairman, Department of Cancer Biology, The University of Texas Anderson Cancer Center 

  • Date/Title Missing

Dr. John Wilkinson

  • “Metabolic Regulation of Pancreatic Cancer by Apoptosis Including Factor” - January 10, 2017                              

Dr. Yan Zhang

  • “Manufacturing Pancreatic Cancer Tissue Microarrays Using 3D Tumor Spheroids” - January 17, 2017

Priyanka Swami

  • "Targeting RAGE in Pancreatic Cancer" (Dr. Leclerc’s group) - January 17, 2017

Jiyan Mohammad

  • “Organotypic and Next Generation Culture Methods” (Dr. Reindl’s group) - January 24, 2017

Dr. Khoda

  • “Bio-manufacturing of Cancerous Pancreas Tissue with Controlled Gradient Scaffold Structure” - February 7, 2017

Michelle Lund

  • “Graphene Oxide Assisted SELEX for the Identification of Aptamers for Pancreatic Cancer Biomarkers” (Dr. Liu’s group) - February 21, 2017

Jagadish Loganathan

  • “GSTP1 Regulation and JNK Activation in Pancreatic Cancer Cells” (Dr. Reindl’s group) - March 7, 2017 

Qiaobin Li

  • “Gold/Silica Nanocomposite-based Lateral Flow Nucleic Acid Biosensors for Sensitive Detection of miRNA-196a” (Dr. Liu’s group) - March 21, 2017

Yi Lu, Ph.D., Department of Chemistry, Biochemistry, Bioengineering, Department of Materials Science and Engineering, and Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign

  • "Functional DNA Nanotechnology and Its Applications As Theranostic Agents for Sensing, Imaging and Targeted Drug Delivery in Cancer Research" - March 23, 2017

Daniel M. Tuvin, M.D., General Surgery, Surgical Oncology, Sanford Broadway Clinic

  • "The Current State of Diagnosis and Treatment of Pancreatic Cancer" - April 4, 2017

Sunitha Takalkar

  • “Development of Lateral Flow Nucleic Acid Biosensors for the Detection of Pancreatic Cancer miRNA Biomarkers” (Dr. Liu’s group) - April 18, 2017

Kevin P. Francis, Ph.D., Preclinical Imaging, PerkinElmer

  • April 18, 2017

Kwaku Baryeh

  • "Development of Lateral Flow Strip Biosensors for the Detection of Pancreatic Cancer Protein Biomarker: CA 19-9” (Dr. Liu’s group) - May 2, 2017

Rahul Singh

  • "GSTP1 knockdown and inhibition impairs pancreatic ductal adenocarcinoma growth (PDAC)" (Dr. Reindl’s group)  - May 2, 2017

Dr. Estelle Leclerc

  • “Targeting RAGE in Pancreatic Cancer” - June 13, 2017

Dr. Katie Reindl 

  • “Combination Therapy:  Targeting Pancreatic Cancer with a ROS Inducer and Gemcitabine” - June 27, 2017

Dr. Guodong Liu 

  • “Magnetic Carbon Nanotube for Visual Detection of Pancreatic Cancer Biomarkers in Whole Blood” - July 11, 2017

Dr. Mohi Quadir 

  • “Spatially-controlled, Combination Drug Delivery Platform Using pH-responsive Polymersomes for Pancreatic Cancer” - July 25, 2017

 


Student Focused. Land Grant. Research University.

Follow NDSU
  • Facebook
  • Twitter
  • RSS
  • Google Maps

North Dakota State University
Phone: +1 (701) 231-5192
Campus address: Sudro Hall 102
Physical/delivery address: 1401 Albrecht Blvd, 136 Sudro Hall, Fargo, ND 58102
Mailing address: NDSU Dept. 2665 / PO Box 6050 / Fargo, ND 58108-6050
Page manager: NDSU Department of Pharmaceutical Sciences

Last Updated: Tuesday, September 19, 2017 12:23:25 PM
Privacy Statement